Article

How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from Turkey

2020-12-08

Abstract excerpt

OBJECTIVE: It is believed that patients with the rheumatic disease have an increased risk of infection due to immune system dysregulation, immunosuppressive treatment, and concomitant comorbidities. In this study, our aim was to detect the frequency of Covid-19 infection among our rheumatology out-patients and to investigate how patient follow-up differed during Covid-19 pandemic. <br>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fe945e0d-bff0-5211-9dbb-a0157f268e7f
DOI: 10.2139/ssrn.3728790

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

How Did COVID-19 Pandemic Affect Rheumatology Out-Patients Practice? A Single-Center Experience from TurkeyDOI 10.2139/ssrn.3728790Read

Clinical Features of Rheumatic Patients with Biologics Treatment Infected with COVID-19 in ChinaSemantic proximity Read

A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic DiseasesSemantic proximity Read

Covid 19 Infection in Patients with Rheumatic Immune-Mediated Diseases in a Single University Hospital. Matched Case-Control Study and Literature Review.Semantic proximity Read

Biologic agents for rheumatic diseases in the break of COVID-19: friend or foe?Semantic proximity Read

UNVACCINATED PATIENTS WITH SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES HAVE HETEROGENEOUS AND UNRELATED RISKS OF COVID INFECTION AND POOR OUTCOMESemantic proximity Read

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELYSemantic proximity Read

Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugsSemantic proximity Read

Immuno-inflammatory rheumatic diseases and COVID-19: analysis of clinical outcomes according to the data of the register of patients of the Novosibirsk region receiving therapy with genetically engineered biological drugsSemantic proximity Read

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity Read

COVID-19 in rheumatic diseases: A random cross-sectional telephonic surveySemantic proximity Read

Assessment of Impact of the COVID-19 Pandemic from the Perspective of Patients with Rheumatic and Musculoskeletal Diseases in Europe: Results from the REUMAVID Study (Phase 1)Semantic proximity Read

The Impact of The COVID-19 Pandemic on The Incidence of Adult and Pediatric Inflammatory ArthritisSemantic proximity Read